Anpario, the animal health and nutrition specialist, reported a solid first half of 2026 when it published interim results on 9 September 2026. Sales rose 7% to £24.3 million and adjusted EBITDA climbed 22% to £5.0 million, while diluted adjusted Earnings Per Share advanced 30%. The board lifted the Interim Dividend by 6% and said it remained confident in the group's prospects, even as conditions in Asia softened the start to the second half.

What the company does

Anpario produces and sells natural feed additives intended to support animal health, nutrition and biosecurity for livestock producers. Its products are sold internationally, and the company regularly highlights the geographic diversity of its customer base as a strength. That spread of markets means results can be shaped by regional farming cycles, disease pressures and local economic conditions as much as by the UK.

Latest developments

The interim results for the six months to 30 June 2026 showed profit before tax up 11% to £3.8 million. Growth in adjusted EBITDA outpaced the increase in sales, suggesting improved Operating Leverage during the period. The company noted that its Asian Business had been affected by the conflict involving Iran, which weighed on trading at the start of the second half.

Alongside the results, Anpario hosted an investor presentation through the Investor Meet Company platform on 9 September 2026. In its outlook, the board pointed to business development initiatives, a strong order pipeline and the breadth of its geographic footprint as reasons for confidence.

Earlier in the year the company ran a share buyback of up to £3.0 million. In an announcement on 27 July 2026, Anpario confirmed the programme was complete, having repurchased 556,803 shares at an average price of 538.79 pence. Following the cancellation of treasury shares, the company said its issued Share Capital would stand at 20,039,026 shares.

Financial and dividend picture

The interim dividend was set at 3.8p per share, an increase of 6% on the previous year's equivalent payment. Taken together with the completed buyback, the dividend shows the board returning capital to shareholders while continuing to invest in growth. The 30% rise in diluted adjusted earnings per share was helped both by higher profits and by the reduced share count resulting from the buyback.

Shareholder register changes were also disclosed, with holding notifications published on 28 July and 28 October 2026. Separately, the company announced on 17 August 2026 the death of a non-executive director.

Sector and index context

As a constituent of the FTSE AIM All Share Index, Anpario sits among a relatively small group of profitable, dividend-paying industrial and agricultural businesses on London's junior market. Its exposure to global livestock production links its fortunes to Demand for protein, feed costs and regulation around antibiotic use in farming, themes that affect animal health suppliers worldwide.

Key risks

The softer start to the second half in Asia illustrates how geopolitical events can disrupt trading in individual regions. Currency movements, raw material costs and the pace of customer orders in export markets are further variables. The company's relatively small size means that changes in a handful of markets can have a noticeable effect on group results.

What to watch next

Investors will look for evidence that the order pipeline cited by the board converts into second-half sales, and for any update on conditions in Asia. Full-year results for 2026 will show whether the strong first-half earnings growth has been sustained and how the board approaches the final dividend and any further capital returns.